Skip to main content
Download PDF

LPL, FNDC5 and PPARγ gene polymorphisms related to body composition parameters and lipid metabolic profile in adolescents from Southern Italy

Journal of Translational Medicine volume 20, Article number: 107 (2022) Cite this article

Abstract

Background

Plasma lipid profile and anthropometric variables are known to be under strong genetic control and the identification of genetic variants associated with bioclinical parameters is of considerable public health importance. In this study, a young cohort of healthy individuals was genotyped for genes related to health and pathological conditions, to analyze the association of single nucleotide polymorphisms (SNPs) with different bioclinical parameters, adherence to the Mediterranean Diet (MD) and physical activity, studying the role of lifestyle and body composition parameters on biochemical metabolic profile.

Methods

Association analysis of single variants in the genes of lipoprotein lipase (LPL), fibronectin type III domain containing protein 5 (FNDC5), and peroxisome proliferator-activated receptor-gamma (PPARγ) and haplotype analyses were performed.

Results

Multiple (n = 14) common variants in the three genes demonstrated a significant effect on plasma lipoprotein-lipid levels and/or on biochemical parameters in our sample. Specifically, SNPs were related to lipid metabolism (rs3866471, rs4922115, rs11570892, rs248, rs316, rs1059507, rs1801282) or glycemic profile (rs3208305) or anthropometric parameters (rs3480, rs726344, rs1570569) for a total of 26 significant associations (P < 0.01 and/or P < 0.05) and two haplotypes, for the first time, were strongly associated with lipid and body composition parameters. Interestingly, we identified twenty-four new variants not previously described in the literature and a novel significant association between rs80143795 and body composition.

Conclusions

In this study we confirm the association between these SNPs on lipid metabolism and body parameters also in a young cohort, indicating the important role of these genetic factors as determinants of health.

Background

Increasing scientific evidence has shown that predisposition to a particular health condition is not due to the modification of a single gene but to the variation of multiple genes located in numerous parts, or loci, of the chromosomes that can be affected by the interaction with the surrounding environment. Among the environmental factors, proper nutrition and regular physical activity can improve the quality of life contributing to a good state of health [1].

Therefore, much of the current biomedical research is based on the expectation that understanding the genetic contribution to health status will revolutionize the diagnosis, treatment, and prevention of diseases [2].

DNA sequence variation analysis is becoming a prominently important source of information for identifying genes involved in both normal biological and disease processes, such as development, aging, and reproduction. In this context, information about genetic variation is critical for understanding how genes work or malfunction and genetic and functional variation correlate.

In particular, individual lipid profiles appear to be strictly determined by lifestyle (smoking, diet, and physical activity). Family studies suggested that in many populations about half the variation in these traits is genetically determined and the concentrations of LDL cholesterol, HDL cholesterol, and triglycerides are strongly influenced by individuals’ genetic makeup. Indeed, genetic variants represent a substantial fraction of individual variation in lipid concentrations [3]. However, several articles focusing on the role of genetic variation in anthropometric and body composition parameters have revealed genetic markers that influence the functional response of the human body to regular physical activities [4, 5], the legacy of these parameters remains unclear.

Lipoprotein lipase (LPL), fibronectin type III domain containing protein 5 (FNDC5—precursor of irisin), and peroxisome proliferator-activated receptor gamma (PPARγ) are well-known candidate genes since the key roles of their products in lipid and energy metabolism and/or their involvement in the pathogenesis of various complications of dyslipidemia has been extensively documented [6,7,8,9]. In particular, LPL encodes the lipoprotein lipase enzyme which hydrolyzes triglycerides and functions as a ligand/bridge factor for receptor-mediated absorption of lipoproteins; FNDC5 encodes a protein that is released by muscle cells during exercise and regulates energy metabolism by converting white to brown fat, contributing to muscle adipose tissue cross-talk; PPARγ encodes for a member of PPAR family of nuclear receptors which is an important adipogenic regulator and a modulator of intracellular insulin-signaling events [10,11,12].

Several traditional SNP genotyping methods based on single traditional PCR or PCR real-time with fluorescent probes are commonly used in genetic research. However, the decreasing cost coupled with rapid progress in Next Generation Sequencing (NGS) and related bioinformatic computing resources have facilitated large-scale discovery of SNPs, genotyping thousands of SNPs in one run. This study aimed at identifying genetic polymorphisms in LPL, FNDC5, and PPARγ, using high-performance technologies combined with the evaluation of biochemical and anthropometric/body composition parameters, in healthy Italian adolescents enrolled in the Mediterranean Diet and Sport research program.

Methods

Subjects

The study was carried out between December 2018 and January 2021 at the laboratory of Medical Genetics, Department of Pharmacy and Health and Nutritional Sciences, University of Calabria. A sample of 92 (44 females and 48 males) genetically unrelated, healthy subjects of Caucasian descent (aged 14–17 years), was recruited from students at the public high school “Istituto Istruzione Superiore”—Castrolibero (CS). Biochemical blood tests were performed to complement the evaluation of the individual’s overall status. Measurements of anthropometric characteristics, body composition parameters, and physical activity levels of participants enrolled within the Italian project DIMENU (Dieta Mediterranea and Nuoto) were previously described [13,14,15]. The questionnaire of Adherence to the Mediterranean Diet (MD), KIDMED Test, was used to assess the adherence to the MD in the study population with the score ranging from 0 to 12 points. In addition, the intensity of physical activity levels were defined based on the WHO recommendations (https://www.who.int/news-room/fact-sheets/detail/physical-activity) and adolescents were grouped in physical inactivity (Group A; < 3 METs), moderate physical activity (Group B; 3–6 METs), and vigorous-intensity physical activity (Group C; > 6 METs). Table 1 reports demographic and lifestyle characteristics of the participants. Considering that sample integrity is critical in genomic experiments and several variables (e.g. collection and storage) may influence it, 77 DNA samples underwent targeted genetic sequencing. (Table 1). Parents of all participants provided written informed consent and the study was conducted according to the guidelines established in the Declaration of Helsinki and approved by the Ethics Committee of the University of Calabria, Italy (# 5727/2018).

Table 1 Characteristics of study participants
Full size table

Genotyping

Genomic DNA was extracted from peripheral blood leukocytes using the Wizard Genomic DNA Purification Kit (Promega). The quantity and quality of DNA were assessed by using the NanoDrop spectrophotometer (NanoDrop™ One/OneC Microvolume UV–Vis Spectrophotometer; Thermo Fisher Scientific) and tested on agarose gel. NGS analysis was carried out using a targeted panel including genes and polymorphisms (see Additional file 1: Table S1), [16–29] related to diet, lifestyle, and physical performance/sports, on the Ion Gene Studio S5 platform (Thermo Fisher Scientific). The genes and specific SNPs were chosen for sequencing based on their significant biological roles in the lipid metabolic pathways and/or correlation with bioclinical parameters. The custom gene-panel was designed online using the Ion AmpliSeq™ Designer (https://ampliseq.com/browse.action) and resulted in 2-primer pools that are able to amplify 200 amplicons covering all the genes, with an amplicon range size of 125–275 bp. In particular, all the coding regions of genes were targeted including at least 25 bp of intronic flanking regions, and the promoter region of the following 9 out of 13 genes: FNDC5, IL-6, CRP, HFE, TNF, IL1B, TGFB1, LPL, HMGCR. The total size of the panel was 37.28 kb. Libraries were prepared using the Ion AmpliSeq™ Library Kit Plus following standard protocols and quantified using the Invitrogen™ Qubit™ Fluorometer to determine the dilution factor resulting in a concentration of ~ 100 pM. Balanced pooled libraries underwent template preparation and enrichment before being purified by using the Ion OneTouch™ ES (Thermo Fisher Scientific), according to the manufacturer’s protocol. The Ion Sphere Particles were loaded onto three different Ion 520 chips and sequenced with the Ion S5™ Sequencing Kit, using the Ion S5™ Sequencer (Thermo Fisher Scientific).

Data analysis

Primary bioinformatic analysis (alignment against the GRCh37/hg19 human reference genome, quality and coverage analysis, and variant calling) was performed using the Torrent Suite™ Software 5.12 (Thermo Fisher Scientific), while the Variant Caller Parameter was set on ‘Germline–Low Stringency’ and annotated variants were filtered for genotype quality (GQ) < 5, flow space read depth (FDP) < 6, variant quality (QUAL) < 20, flow space alternate allele observations (FAO) < 2. The main coverage sequence was 30X. To compare our genotype frequencies, 1000GENOMES (www.1000genomes.org/1000-genomes-browsers) and GnomAD (gnomad.broadinstitute.org) databases were used, excluding the variants with very low frequencies (MAF < 1%), since the aim of our work was not to evaluate the pathogenic impact of rare variants.

Linkage disequilibrium (LD) and haplotype analysis

Haploview (Barrett et al. 2005, www.broadinstitute.org/haploview) was used to determine the linkage disequilibrium (LD) between variants, to test the concordance of the genotype distribution with Hardy–Weinberg equilibrium and selecting representative SNPs of common variants (so-called tagSNPs) with MAF ≥ 0.05 by performing tagger analyses.

DnaSp v6 software was used for LPL haplotype reconstruction. The algorithm provided by PHASE [30] was used with 100 iterations, thinning intervals equal to 1, and 100 burn-in iterations [31].

Association analysis

Association analysis by using single SNPs and haplotype with biochemical and body composition parameters was conducted using the general linear model (GLM) performed by Tassel 5.2.51v. For each marker-genotype combination, GLM finds the solution of ordinary least squares. The Tassel 5.2.51v software calculated the genotypic effect and not the allelic effect as deviations from the estimated value of the lower frequency genotype class. The class with the lowest frequency is set as zero effect, then the other genotype effects are given as deviations between their estimated values and the lowest frequency class [32]. Both the Fisher’s exact test and Chi-square test were used for evaluating significant pairwise associations and Bonferroni correction was also applied.

The effect of polymorphisms as well as of physical activity, WHR and KIDMED score on circulating levels of total cholesterol, LDL cholesterol, and triglycerides was investigated by calculating the explained variance (in percentage) of each of the biomarkers provided by each single polymorphism, WHR, and KIDMED score. Furthermore, to assess the independent effect of polymorphisms on total cholesterol, LDL cholesterol, and triglycerides, beyond and above the potential confounding effect of physical activity, WHR, KIDMED, and gender, multiple linear regression models were fitted. In these models, the strength of the relationship between each polymorphism and lipids was expressed as beta regression coefficients, and P values.

eQTL analysis

Expression Quantitative Trait Loci (eQTL) analysis was performed using Genotype-Tissue Expression GTEx Portal v.8 (www.gtexportal.org) (eQTL), a data resource and tissue bank to study the relationship between genetic variants and gene expression in multiple human tissues and between individuals, for a better understanding of the genetic determinism of quantitative traits.

Results

NGS results

Targeted panel sequencing in 77 samples of healthy adolescents identified a total of 1964 variants. Two hundred and eight variants were found in the three genes of interest (LPL, FNDC5, PPARγ). Annotated variants were then filtered for quality parameters (FAO, FDP, GQ, QUAL) confirming the true positive calls. Of the 208 variants identified, 111 SNPs passed the quality filters (61 in LPL, 38 in FNDC5 and 12 in PPARγ) (see Additional file 2: Table S2). Of these, 33 were insertions or deletions, 77 were single nucleotide variants and 1 substitution. The proportions of the 78 substitutions were: A/G, 14,1%; A/C, 7,5%; A/T, 5%; C/A, 8,7%; C/T, 16,6%; C/G, 5,1%; G/A, 14,1%; G/C, 2,6%; G/T, 6,4%; T/A, 2,6%; T/C; 16,6%; T/G, 2,6%.

Twenty-four of the total variants have not been previously described in the literature. In particular, 11 in LPL gene, 12 in FNDC5, and 1 in PPARγ. Among these, 21 SNV and 3 INDEL (see Additional file 2: Table S2). Of the 111 variants identified, 40 were located in the intronic region and 53 in the flanking regions (42 in 3'UTR, 4 in 5'UTR, 4 in upstream, 1 in an intergenic region, and 2 in a regulatory region). The remaining 18 variants were exonic (4 frameshift and 14 single substitutions) including one a stop codon variant. Of the 18 coding variants, three resulted in non-synonymous changes in PPARγ, from proline to alanine (P12A), from glycine to tryptophan (G290W), from lysine to glutamine (K156E), and two frameshift (L178Tfs*2; D7Rfs*5); three variants resulted in FNDC5 of which one frameshift (L132Ffs*6) and two SNVs, leucine to valine (L81V) and histidine to asparagine (H127N); nine resulted in LPL including 4 synonymous variants, valine to valine (V135V), threonine to threonine (T388T), leucine to leucine (L81L), glutamate to glutamate (E145E); 4 non-synonymous changes, asparagine in serine (N318S), arginine to histidine (R197H), histidine to proline (H348P), aspartate in asparagine (E36N); one stop codon variant in exon 9 (S474X) and finally one frameshift (Q118Hfs*30).

Of the 24 novel variants that we identified, 5 had MAF ≥ 0.05, 2 had MAF between 0.05–0.01, and 17 had MAF < 0.01.

Single SNP and multivariate analyses

To identify tagSNPs in our cohort we used Haploview software v4.2. Fifty-two common SNPs were identified using R2 value of 0.8 of which 34, 19, and 3 in LPL, FNDC5, and PPARγ genes, respectively. For FNDC5 and PPARγ no SNPs were in LD unlike some other SNPs in the LPL gene (rs11570892, rs4922115, rs1059507, and rs3866471). Subsequently, the relationship between these SNPs and either body composition assessment or lipid profile and insulin levels was investigated using the general linear model (GLM) by Tassel software, allowing to identify 58 significant associations (P < 0.01 and/or P < 0.05) after Bonferroni corrections. Among these, 26 related to parameters of our interest (WHR, TBW, FFM, FM, BCM, BMR, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides and insulin). Figure 1 shows significant associations between tag-SNPs and parameters related to lipid profile, anthropometric characteristics, and body composition.

Fig. 1
figure 1

Significantly associated SNPs with different body composition parameters, lipid profile, and insulin levels in our cohort. The X-axis indicates the genotype status (letters) R2: is the statistical used for association analysis and p is the Benjamini–Hochberg Adjusted p-value. The associations of the polymorphisms in the three different genes are distinguished by squares of different colors: FNDC5 in yellow, PPARγ in orange, and LPL in green

Full size image

Moreover, the effects of LPL polymorphisms as well as of physical activity, WHR and KIDMED score on circulating levels of total cholesterol, LDL cholesterol, and triglycerides are given in Fig. 2. As shown, the rs4922115 polymorphism was the first factor in rank explaining the total cholesterol and LDL cholesterol variability (rs4922115, rs11570892, rs1059507, and rs3866471 are in linkage disequilibrium, which explains the analysis result by GLM in which rs11570892 was the only one significantly associated with total cholesterol and LDL cholesterol levels) whereas the rs316 polymorphism resulted to be the first factor in rank explaining the variability of triglycerides (according to the ordinary linear regression analysis). Of note, physical activity, WHR, and KIDMED score largely failed to explain the variance of total cholesterol and LDL cholesterol (P = NS). Physical activity and WHR only explained the variability of triglycerides, but the strength of these associations was lower than that of polymorphisms.

Fig. 2
figure 2

Lipid profile related to LPL polymorphisms and environmental factors. PA physical activity, WHR waist/hip ratio. Dependent (plasma lipid parameters) and independent (genotypes, PA, WHR, and KIDMED score) variables

Full size image

It is worth noting that the genetic variants of LPL gene are located in 3’UTR with the exception of rs316. The analysis of variance for each SNP related to the lipid profile is shown in Table 2.

Table 2 LPL polymorphisms and analysis of variance related to blood lipid values
Full size table

Determining the grade of conservation of these variants by phastCons and phyloP methods [33], based on the multiple alignments of genome sequences of 46 different species, we observed that rs4922115 is the most conserved polymorphism, followed by rs11570892, rs3866471, while rs1059507 is the least conserved. Of note, data adjustment for confounders such as physical activity, KIDMED, WHR, BMI and gender did not affect the relationship between each polymorphism and serum lipids but for the links between rs11570892 and rs1059507 with serum triglycerides which just failed to reach the formal statistical significance (Table 3).

Table 3 Multiple linear regression models of lipids and LPL polymorphisms
Full size table

Haplotype analysis

Haplotype analyzes have been shown to be advantageous over single SNP analysis in the presence of multiple susceptibility alleles, particularly when SNPs are poorly correlated with each other [34]. Considering the small number of polymorphisms detected in two (FNDC5 and PPARγ) of the three analyzed genes, we reconstructed the haplotypes using DnaSP logistic regression analysis for the LPL gene only. LPL haplotype reconstruction and analyses on significantly associated LPL polymorphisms (rs248, rs249, rs4922115, rs11570892, rs3208305, rs1059507, rs3866471) generated 27 different haplotypes. After excluding "very rare haplotypes" (haplotype detected in 1–2 samples out of 77) the blocks of haplotypes containing significant SNPs from the single SNP analysis to reduce multiple tests were tested for subsequent association analysis by the Tassel software using a GLM model. In particular, 9 distinct haplotypes were analyzed. GLM procedures identified associations between LPL haplotypes and parameters in our cohort, revealing 3 associations of blocks with lipid/body composition parameters, including: haplotype 3 (rs316, rs11570892, rs4922115, rs3866471, rs1059507, rs3208305), associated with increased levels of triglycerides (p = 0.002) and total cholesterol (p = 0.01); haplotype 4 (rs249, rs3208305), associated with the reduction of FFM (p = 0.003) (Fig. 3).

Fig. 3
figure 3

Significantly associated LPL haplotype with body composition and lipid parameters. The X-axis indicates the presence (+) or absence of the haplotype (−).eQTLs

Full size image

In order to understand the functional consequences of these genetic variations based on non-coding regions and how these affect quantitative traits, we evaluated the impact of genetic variations on gene expression in different human tissues, including the main users of fatty acids, through their eQTL mapping. Data retrieved from GTEx Portal v.8 showed a concordant tissue-specific effect for 5 LPL variants supporting their potential regulatory impact on the lipid parameters examined (Table 4).

Table 4 Variant tissue-specific effects by eQTLs analysis on LPL gene
Full size table

Discussion

In this study, to increase the understanding of the interaction between LPL, PPARγ, and FNDC5 genes with lipid metabolic profile as well as body composition parameters, under non-pathological conditions, we have thoroughly evaluated the presence of novel and already discovered SNPs and their potential associations in young adolescents.

The role of many genetic variations in relation to lipid levels has already extensively been studied [12, 35, 36]. GWAS studies revealed that SNPs in the LPL are associated with levels of cholesterol, triglycerides, and more, as well as numerous molecular phenotypes are related to human diseases and diseases risk [6, 37, 38]. Furthermore, controversial data have been reported on the association (positive, null, or negative) between irisin levels and BMI, body weight and FM in different populations [39,40,41] and different associations between lipid intake and BMI in carriers and non-carriers of PPARγ polymorphisms have been observed [42].

In our cohort, we identified 111 variants, of which 24 were novel. All genotyped variants were in concordance with Hardy–Weinberg equilibrium expectations. The single SNP analysis, performed by linear regression, revealed 26 significant associations (p < 0.05) of which 10 with body composition parameters and 16 with lipid profiles. The best associated PPARγ SNP with FFM was rs3856806 (p = 0.009) while FNDC5 SNPs significantly associated with FFM (rs726344, p = 0.02), FM and WHR (rs3480, p = 0.02; p = 0.03 respectively), and TBW (rs1570569, p = 0.03). A significant association, never previously described, was identified between the intronic variant c.775 + 80A > G in LPL, rs80143795, and FFM, BCM, and BMR.

In this study, the LPL haplotype association results, largely comparable with the single-site analyses, revealed two main blocks (3 and 4) significantly associated with lipid and body composition parameters never reported before. In addition, considering the explained variance effects of LPL polymorphisms, physical activity, WHR, and KIDMED score on lipid profile, we discovered that rs316 and rs4922115 were the main factors explaining the variability of triglycerides and total/LDL cholesterol, respectively. The rs316 is a synonymous variant located in exon 8 not in linkage disequilibrium with other identified SNPs, previously described to be associated with HDL cholesterol in a healthy African Black population [43]. On the other hand, the individual effect of the non-coding rs4922115 on blood lipids has not been previously investigated in other populations except in Asian Indians [44]. However, this study did not report any statistically significant interaction between this SNP and lipid parameters. In our study rs4922115, such as rs316, was part of haplotype block 3 and was in LD with rs11570892, rs1059507, and rs3866471 (R2 = 0.58–0.67). In particular, most of these SNPs are located in the 3’UTR of the gene known to be involved in gene regulation, affecting LPL mRNA levels, or post-transcriptional changes [45].

Several genetic polymorphisms in the 3′-UTR of different genes influencing gene expression, have already been reported in humans relating to various disorders. For example, rs1059611, significantly associated with increased HDL and decreased TG concentrations in patients with coronary heart disease, affects mRNA stability and LPL expression. Specifically, in homozygous and heterozygous states, the C allele carriers show increased gene expression [46]. In addition, a functional study of rs6773957, strongly associated with plasma adiponectin levels and body weight in patients affected by metabolic syndrome, indicates that this variant may affect mRNA stability influencing the expression of ADIPOQ [47]. Very often, 3’UTR SNPs influence gene expression by secondary structures, in the form of stem-loops on the mRNA [48] such as rs27770 of Polo-like Kinase 1 (PLK1) which, showing variations in secondary mRNA structures and stability, leads to increased gene expression [49].

Different studies have been strongly associated these 3’UTR-SNPs with HDL cholesterol and TG levels, especially in Europeans [50, 51]. Moreover, it has been previously shown that haplotypes in these regions modulate pathologies such as atherosclerosis, insulin resistance, blood pressure, and obesity [52].

Interestingly, the study of genetic variations identified in the LPL gene on the molecular and/or phenotypic consequences through genome-wide mapping of the eQTL analysis showed the increased expression of rs4922115 and other 4 unique eQTL SNPs (rs11570892, rs3208305, rs1059507, and rs3866471) in thyroid and adipose subcutaneous tissues, supporting the impact of these variants on the lipid parameters examined (Table 4). Among all these eQTL variants, rs3208305, found to be significantly associated with insulin levels in this study, showed a very strong deregulated expression also in other tissues such as adipose visceral and whole blood. However, determining causal variants, molecular mechanisms and relevant tissues contributing to these associations can be difficult, largely due to the ability of numerous tissues to synthesize and metabolize fatty acids [53]. Furthermore, the concordant deregulated expression of LPL gene SNPs in the thyroid tissue should not surprise considering the contribution of thyroid hormones to energy expenditure, heat production, and direct regulation of basal metabolism [54].

Overall, despite recent studies suggest that a high-quality diet affects well-being [55], a "healthy" lifestyle is not enough to prevent potential conditions “at-risk”. In addition to physical activity and muscle mass, other factors, such as hormonal structure, temperature, and genetics, influence basal metabolism [56]. Our results showed that SNPs constituting the haplotypes were significantly associated with different lipid parameters (triglycerides, total cholesterol, and LDL cholesterol), while lifestyle habits, such as adherence to MD and physical activity, as well as WHR did have a low or null impact in healthy adolescents, highlighting the important role of genetic variants.

It is worth noting that the importance of diet and exercise in preventing cardiovascular disease among healthy young adults has been recently confirmed [57, 58]. Therefore, large-scale longitudinal studies evaluating the outcome among these young adults will be helpful for better identification and modification of risk factors in certain high-risk haplotypes.

Several variables influencing the interpretation of data in our cohort and/or explaining different results from previous studies include the use of sampling criteria (e.g. affected population/healthy population; inclusion of very young subjects compared to those predominantly selected, ethnicity, etc.) different software tools and algorithms applied for variant analysis, although the major limitation of this study is the sample size used for association analyses.

Overall, this cohort study of young healthy individuals is of significant importance since it will add new knowledge to the role of genetic factors in maintaining health status. In fact, cataloguing of DNA polymorphisms in different populations is critical to the development of genome-based knowledge about an individual's susceptibility to many common diseases and, at the same time, will be essential to produce a safer and more effective individualized diet.

In future, it is hoped that research will unveil ways to make SNP useful markers for clinical setting. Finding out how SNPs affect the health of an individual and then transforming this knowledge into the development of new drugs will undoubtedly revolutionize the treatments of the most common devastating disorders.

Conclusions

To the best of our knowledge, this study is the first investigation reporting the analysis of sequence variations in the LPL, PPARγ, and FNDC5 genes and their associations with anthropometric/body composition and lipid traits, in young healthy individuals, who adhere to the MD and perform physical activity.

While our results support, even in a young cohort, previously reported data on the association of non-coding SNPs and lipid parameters, on the other hand, it emerges the fundamental contribution in these associations of the genetic component with respect to the environmental factors.

However, despite the large number of significant associations between SNPs and phenotypes, most associations have not yet been replicated, which is why further studies are needed to better elucidate the role of these variants in affecting interindividual variation in plasma lipid phenotypes, leading to improvements in quality of life through better preventive strategies.

Availability of data and materials

The data presented in this study are available in results and additional files sections.

Abbreviations

SNPs:

Single nucleotide polymorphisms

MD:

Mediterranean diet

LPL:

Lipoprotein lipase

FNDC5:

Fibronectin type III domain containing protein 5

PPARγ:

Peroxisome proliferator-activated receptor gamma

PCR:

Polymerase chain reaction

NGS:

Next generation sequencing

DIMENU:

Dieta Mediterranea and Nuoto

BMI:

Body mass index

WHR:

Waist/hip ratio

TBW:

Total body water

BMR:

Basal metabolic rate

FFM:

Free fat mass

FM:

Fat mass

GQ:

Genotype quality

FDP:

Flow space read depth

QUAL:

Variant quality

FAO:

Flow space alternate allele observations

MAF:

Minor allele frequency

GLM:

General linear model

eQTL:

Expression quantitative trait loci

LD:

Linkage disequilibrium

GWAS:

Genome-wide association study

References

  1. MacRae CA, Vasan RS. The future of genetics and genomics: closing the phenotype gap in precision medicine. Circulation. 2016;133(25):2634–9. https://doi.org/10.1161/CIRCULATIONAHA.116.022547.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Di Renzo L, Cioccoloni G, Falco S, Abenavoli L, Moia A, Sinibaldi Salimei P, De Lorenzo A. Influence of FTO rs9939609 and Mediterranean diet on body composition and weight loss: a randomized clinical trial. J Transl Med. 2018;16(1):308. https://doi.org/10.1186/s12967-018-1680-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narcissus N, Bennett D, Parish S, Shen H, Galan P, Menton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, U da M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40(2):161–9. https://doi.org/10.1038/ng.76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Brener A, Waksman Y, Rosenfeld T, Levy S, Peleg I, Raviv A, Interator H, Lebenthal Y. The heritability of body composition. BMC Pediatr. 2021;21(1):225. https://doi.org/10.1186/s12887-021-02695-z.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Leońska-Duniec A, Świtała K, Ahmetov II, Pickering C, Massidda M, Buryta M, Mastalerz A, Maculewicz E. FABP2 Ala54Thr polymorphism and post-training changes of body composition and biochemical parameters in Caucasian women. Genes (Basel). 2021;12(7):954. https://doi.org/10.3390/genes12070954.PMID:34206471;PMCID:PMC8305881.

    Article  Google Scholar 

  6. Dron JS, Hegele RA. Genetics of hypertriglyceridemia. Front Endocrinol (Lausanne). 2020;24(11):455. https://doi.org/10.3389/fendo.2020.00455.

    Article  Google Scholar 

  7. Gross B, Pawlak M, Lefebvre P, Staels B. PPARs in obesity-induced T2DM, dyslipidemia and NAFLD. Nat Rev Endocrinol. 2017;13(1):36–49. https://doi.org/10.1038/nrendo.2016.135.

    Article  CAS  PubMed  Google Scholar 

  8. Cheng HS, Tan WR, Low ZS, Marvalim C, Lee JYH, Tan NS. Exploration and development of PPAR modulators in health and disease: an update of clinical evidence. Int J Mol Sci. 2019;20(20):5055. https://doi.org/10.3390/ijms20205055.

    Article  CAS  PubMed Central  Google Scholar 

  9. Flori L, Testai L, Calderone V. The, “irisin system”: from biological roles to pharmacological and nutraceutical perspectives. Life Sci. 2021;15(267): 118954. https://doi.org/10.1016/j.lfs.2020.118954.

    Article  CAS  Google Scholar 

  10. Basu D, Goldberg IJ. Regulation of lipoprotein lipase-mediated lipolysis of triglycerides. Curr Opin Lipidol. 2020;31(3):154–60. https://doi.org/10.1097/MOL.0000000000000676.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shen C, Fan W, Xie HJ, Wu M, Zhou ZY, Guo ZR, Dong C. Haplotype analysis of PPARγ gene polymorphisms and the lipoprotein (a) level. Iran J Public Health. 2018;47(7):973–9.

    PubMed  PubMed Central  Google Scholar 

  12. Cao RY, Zhang H, Redfearn D, Yang J. FNDC5: a novel player in metabolism and metabolic syndrome. Biochimie. 2019;158:111–6. https://doi.org/10.1016/j.biochi.2019.01.001.

    Article  CAS  PubMed  Google Scholar 

  13. Morelli C, Avolio E, Galluccio A, Caparello G, Manes E, Ferraro S, De Rose D, Santoro M, Barone I, Catalano S, Andò S, Sisci D, Giordano C, Bonofiglio D. Impact of vigorous-intensity physical activity on body composition parameters, lipid profile markers, and irisin levels in adolescents: a cross-sectional study. Nutrients. 2020;12(3):742. https://doi.org/10.3390/nu12030742.

    Article  CAS  PubMed Central  Google Scholar 

  14. Morelli C, Avolio E, Galluccio A, Caparello G, Manes E, Ferraro S, Caruso A, De Rose D, Barone I, Adornetto C, Greco G, Catalano S, Andò S, Sisci D, Giordano C, Bonofiglio D. Nutrition education program and physical activity improve the adherence to the mediterranean diet: impact on inflammatory biomarker levels in healthy adolescents from the DIMENU longitudinal study. Front Nutr. 2021;19(8): 685247. https://doi.org/10.3389/fnut.2021.685247.

    Article  CAS  Google Scholar 

  15. Augimeri G, Galluccio A, Caparello G, Avolio E, La Russa D, De Rose D, Morelli C, Barone I, Catalano S, Andò S, Giordano C, Sisci D, Bonofiglio D. Potential antioxidant and anti-inflammatory properties of serum from healthy adolescents with optimal mediterranean diet adherence: findings from DIMENU cross-sectional study. Antioxidants (Basel). 2021;10(8):1172. https://doi.org/10.3390/antiox10081172.

    Article  CAS  Google Scholar 

  16. Todendi PF, Brand C, Silveira JFC, Gaya AR, Agostinis-Sobrinho C, Fiegenbaum M, Burns RD, Valim ARM, Reuter CP. Physical fitness attenuates the genetic predisposition to obesity in children and adolescents. Scand J Med Sci Sports. 2021;31(4):894–902. https://doi.org/10.1111/sms.13899.

    Article  PubMed  Google Scholar 

  17. Razquin C, Martinez JA, Martinez-Gonzalez MA, Fernández-Crehuet J, Santos JM, Marti A. A Mediterranean diet rich in virgin olive oil may reverse the effects of the -174G/C IL6 gene variant on 3-year body weight change. Mol Nutr Food Res. 2010;54(Suppl 1):S75-82. https://doi.org/10.1002/mnfr.200900257.

    Article  CAS  PubMed  Google Scholar 

  18. Arouca AB, Meirhaeghe A, Dallongeville I, Manios Y, Lambrinou CP, Gottrand F, Kafatos A, Kersting M, Sjöström M, Widhalm K, Ferrari M, Molnár D, González-Gross M, Forsner M, DeHenauw S, Michels N, HELENA Study Group. Interplay between the Mediterranean diet and C-reactive protein genetic polymorphisms towards inflammation in adolescents. Clin Nutr. 2020;39(6):1919–26. https://doi.org/10.1016/j.clnu.2019.08.016.

    Article  CAS  PubMed  Google Scholar 

  19. Aranda N, Bedmar C, Arija V, Jardí C, Jimenez-Feijoo R, Ferré N, Tous M, Defensas Study investigators. Serum hepcidin levels, iron status, and HFE gene alterations during the first year of life in healthy Spanish infants. Ann Hematol. 2018;97(6):1071–80. https://doi.org/10.1007/s00277-018-3256-2.

    Article  CAS  PubMed  Google Scholar 

  20. Garaulet M, Smith CE, Hernández-González T, Lee YC, Ordovás JM. PPARγ Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet. Mol Nutr Food Res. 2011;55(12):1771–9. https://doi.org/10.1002/mnfr.201100437.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY, Friedline RH, Kurt-Jones E, Finberg R, Fischer MA, Granger EL, Norbury CC, Hauschka SD, Philbrick WM, Lee CG, Elias JA, Kim JK. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes. 2009;58(11):2525–35. https://doi.org/10.2337/db08-1261.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Wilson GC, Mavros Y, Tajouri L, Singh MF. The role of genetic profile in functional performance adaptations to exercise training or physical activity: a systematic review of the literature. J Aging Phys Act. 2019;27(4):594–616. https://doi.org/10.1123/japa.2018-0155.

    Article  PubMed  Google Scholar 

  23. Zhang J, Chi H, Xiao H, Tian X, Wang Y, Yun X, Xu Y. Interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) single nucleotide polymorphisms (SNPs), inflammation and metabolism in gestational diabetes mellitus in inner mongolia. Med Sci Monit. 2017;28(23):4149–57. https://doi.org/10.12659/msm.903565.

    Article  CAS  Google Scholar 

  24. Chamberlin T, Thompson V, Hillers-Ziemer LE, Walton BN, Arendt LM. Obesity reduces mammary epithelial cell TGFβ1 activity through macrophage-mediated extracellular matrix remodeling. FASEB. 2020;34(6):8611–24.

    Article  CAS  Google Scholar 

  25. Gao RR, Wang M, Hu Y, Xu CY, Li YC, Zhang ZY, Chen SY, Mao XY. Impact of LPL gene rs283 polymorphism on exercise-induced changes in metabolism of obese adolescents and the regulatory mechanisms behind it. Exp Physiol. 2015;100(6):698–707. https://doi.org/10.1113/EP085127.

    Article  CAS  PubMed  Google Scholar 

  26. Burkhardt R, Kenny EE, Lowe JK, Birkeland A, Josowitz R, Noel M, Salit J, Maller JB, Pe’er I, Daly MJ, Altshuler D, Stoffel M, Friedman JM, Breslow JL. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13. Arterioscler Thromb Vasc Biol. 2008;28(11):2078–84. https://doi.org/10.1161/ATVBAHA.108.172288.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Cortés-Martín A, Colmenarejo G, Selma MV, Espín JC. Genetic polymorphisms, mediterranean diet and microbiota-associated urolithin metabotypes can predict obesity in childhood-adolescence. Sci Rep. 2020;10(1):7850. https://doi.org/10.1038/s41598-020-64833-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Rudkowska I, Dewailly E, Hegele RA, Boiteau V, Dubé-Linteau A, Abdous B, Giguere Y, Chateau-Degat ML, Vohl MC. Gene-diet interactions on plasma lipid levels in the Inuit population. Br J Nutr. 2013;109(5):953–61. https://doi.org/10.1017/S0007114512002231.

    Article  CAS  PubMed  Google Scholar 

  29. Lauritzen L, Sørensen LB, Harsløf LB, Ritz C, Stark KD, Astrup A, Dyssegaard CB, Egelund N, Michaelsen KF, Damsgaard CT. Mendelian randomization shows sex-specific associations between long-chain PUFA-related genotypes and cognitive performance in Danish schoolchildren. Am J Clin Nutr. 2017;106(1):88–95. https://doi.org/10.3945/ajcn.117.152595.

    Article  CAS  PubMed  Google Scholar 

  30. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003;73(5):1162–9. https://doi.org/10.1086/379378.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009;25(11):1451–2. https://doi.org/10.1093/bioinformatics/btp187.

    Article  CAS  Google Scholar 

  32. Bradbury PJ, Zhang Z, Kroon DE, Casstevens TM, Ramdoss Y, Buckler ES. TASSEL: software for association mapping of complex traits in diverse samples. Bioinformatics. 2007;23(19):2633–5. https://doi.org/10.1093/bioinformatics/btm308.

    Article  CAS  PubMed  Google Scholar 

  33. Ramani R, Krumholz K, Huang YF, Siepel A. PhastWeb: a web interface for evolutionary conservation scoring of multiple sequence alignments using phastCons and phyloP. Bioinformatics. 2019;35(13):2320–2. https://doi.org/10.1093/bioinformatics/bty966).

    Article  CAS  PubMed  Google Scholar 

  34. Morris RW, Kaplan NL. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol. 2002;23(3):221–33. https://doi.org/10.1002/gepi.10200.

    Article  PubMed  Google Scholar 

  35. Khamlaoui W, Mehri S, Hammami S, Hammouda S, Chraeif I, Elosua R, Hammami M. Association between genetic variants in FADS1-FADS2 and ELOVL2 and obesity, lipid traits, and fatty acids in Tunisian population. Clin Appl Thromb Hemost. 2020. https://doi.org/10.1177/1076029620915286.

    Article  PubMed  PubMed Central  Google Scholar 

  36. González-Mercado A, Magaña-Torres MT, Sánchez-López JY, Ríos-Silva M, Ibarra-Cortés B, Trujillo X, Huerta M. The relationship of single nucleotide polymorphisms in the TRPV1 gene with lipid profile, glucose, and blood pressure in Mexican population. Genet Test Mol Biomarkers. 2020;24(7):420–4. https://doi.org/10.1089/gtmb.2019.0213.

    Article  CAS  PubMed  Google Scholar 

  37. Cho YS, Go MJ, Han HR, Cha SH, Kim HT, Min H, Shin HD, Park C, Han BG, Cho NH, Shin C, Kimm K, Oh B. Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus. Exp Mol Med. 2008;40(5):523–32. https://doi.org/10.3858/emm.2008.40.5.523.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Zhang X, Johnson AD, Hendricks AE, Hwang SJ, Tanriverdi K, Ganesh SK, Smith NL, Peyser PA, Freedman JE, O’Donnell CJ. Genetic associations with expression for genes implicated in GWAS studies for atherosclerotic cardiovascular disease and blood phenotypes. Hum Mol Genet. 2014;23(3):782–95. https://doi.org/10.1093/hmg/ddt461 (Epub 2013 Sep 20).

    Article  CAS  PubMed  Google Scholar 

  39. Sanchis-Gomar F, Garatachea N, He ZH, Pareja-Galeano H, Fuku N, Tian Y, Arai Y, Abe Y, Murakami H, Miyachi M, Yvert T, Santiago C, Venturini L, Fiuza-Luces C, Santos-Lozano A, Rodríguez-Romo G, Ricevuti G, Hirose N, Emanuele E, Lucia A. FNDC5 (irisin) gene and exceptional longevity: a functional replication study with rs16835198 and rs726344 SNPs. Age (Dordr). 2014;36(6):9733. https://doi.org/10.1007/s11357-014-9733-1.

    Article  CAS  Google Scholar 

  40. Al-Daghri NM, Mohammed AK, Al-Attas OS, Amer OE, Clerici M, Alenad A, Alokail MS. SNPs in FNDC5 (irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjects. Lipids Health Dis. 2016;11(15):54. https://doi.org/10.1186/s12944-016-0224-5.

    Article  CAS  Google Scholar 

  41. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, Hunter DJ. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003;12(22):2923–9. https://doi.org/10.1093/hmg/ddg318.

    Article  CAS  PubMed  Google Scholar 

  42. Pardo M, Crujeiras AB, Amil M, Aguera Z, Jiménez-Murcia S, Baños R, Botella C, de laTorre R, Estivill X, Fagundo AB, Fernández-Real JM, Fernández-García JC, Fruhbeck G, Gómez-Ambrosi J, Rodríguez R, Tinahones FJ, Fernández-Aranda F, Casanueva FF. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol. 2014;2014:857270.

    Article  Google Scholar 

  43. Pirim D, Wang X, Radwan ZH, Niemsiri V, Bunker CH, Barmada MM, Kamboh MI, Demirci FY. Resequencing of LPL in African Blacks and associations with lipoprotein-lipid levels. Eur J Hum Genet. 2015;23(9):1244–53. https://doi.org/10.1038/ejhg.2014.268 (Epub 2015 Jan 28).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Ayyappa KA, Shatwan I, Bodhini D, et al. High fat diet modifies the association of lipoprotein lipase gene polymorphism with high density lipoprotein cholesterol in an Asian Indian population. Nutr Metab (Lond). 2017;14:8. https://doi.org/10.1186/s12986-016-0155-1.

    Article  CAS  Google Scholar 

  45. Ranganathan G, Unal R, Pokrovskaya ID, Tripathi P, Rotter JI, Goodarzi MO, Kern PA. The lipoprotein lipase (LPL) S447X gain of function variant involves increased mRNA translation. Atherosclerosis. 2012;221(1):143–7. https://doi.org/10.1016/j.atherosclerosis.2011.12.028.

    Article  CAS  PubMed  Google Scholar 

  46. Mo X, Liu X, Wang L, Li H, Lu X, Huang J, Chen J, Cao J, Li J, Chen S, Tang Y, Peng X, Gu D. Lipoprotein lipase gene polymorphism rs1059611 functionally influences serum lipid concentrations. Atherosclerosis. 2013;229(2):511–6. https://doi.org/10.1016/j.atherosclerosis.2013.05.005 (Epub 2013 May 18).

    Article  CAS  PubMed  Google Scholar 

  47. Wang Q, Ren D, Bi Y, Yuan R, Li D, Wang J, Wang R, Zhang L, He G, Liu B. Association and functional study between ADIPOQ and metabolic syndrome in elderly Chinese Han population. Aging (Albany NY). 2020;12(24):25819–27. https://doi.org/10.18632/aging.104203 (Epub 2020 Nov 20).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Hren MG. RNA Secondary Structure of 3’UTR Regulates Translation Control. Biol Sci. 2019;62.

  49. Akdeli N, Riemann K, Westphal J, Hess J, Siffert W, Bachmann HS. A 3’UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1. Mol Cancer. 2014;26(13):87. https://doi.org/10.1186/1476-4598-13-87.

    Article  CAS  Google Scholar 

  50. Tang W, Apostol G, Schreiner PJ, Jacobs DR Jr, Boerwinkle E, Fornage M. Associations of lipoprotein lipase gene polymorphisms with longitudinal plasma lipid trends in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Circ Cardiovasc Genet. 2010;3(2):179–86. https://doi.org/10.1161/CIRCGENETICS.109.913426 (Epub 2010 Feb 11).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, Penninx BW, Janssens AC, Wilson JF, Spector T, Martin NG, Pedersen NL, Kyvik KO, Kaprio J, Hofman A, Freimer NB, Jarvelin MR, Gyllensten U, Campbell H, Rudan I, Johansson A, Marroni F, Hayward C, Vitart V, Jonasson I, Pattaro C, Wright A, Hastie N, Pichler I, Hicks AA, Falchi M, Willemsen G, Hottenga JJ, de Geus EJ, Montgomery GW, Whitfield J, Magnusson P, Saharinen J, Perola M, Silander K, Isaacs A, Sijbrands EJ, Uitterlinden AG, Witteman JC, Oostra BA, Elliott P, Ruokonen A, Sabatti C, Gieger C, Meitinger T, Kronenberg F, Döring A, Wichmann HE, Smit JH, McCarthy MI, van Duijn CM, Peltonen L, ENGAGE Consortium. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 2009;41(1):47–55. https://doi.org/10.1038/ng.269 (Epub 2008 Dec 7).

    Article  CAS  PubMed  Google Scholar 

  52. Goodarzi MO, Wong H, Quiñones MJ, Taylor KD, Guo X, Castellani LW, Antoine HJ, Yang H, Hsueh WA, Rotter JI. The 3’ untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity. J Clin Endocrinol Metab. 2005;90(8):4816–23. https://doi.org/10.1210/jc.2005-0389 (Epub 2005 May 31).

    Article  CAS  PubMed  Google Scholar 

  53. Wagenmakers AJM, Frayn KN, Arner P, Hannele Y-J. Fatty acid metabolism in adipose tissue, muscle, and liver in health and disease. Essays Biochem. 2006;42:89–103. https://doi.org/10.1042/bse0420089.

    Article  Google Scholar 

  54. Yavuz S, Salgado Nunez Del Prado S, Celi FS. Thyroid hormone action and energy expenditure. J Endocr Soc. 2019;3(7):1345–56. https://doi.org/10.1210/js.2018-00423.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Esteban-Gonzalo L, Turner AI, Torres SJ, Esteban-Cornejo I, Castro-Piñero J, Delgado-Alfonso Á, Marcos A, Gómez-Martínez S, Veiga ÓL. Diet quality and well-being in children and adolescents: the UP&DOWN longitudinal study. Br J Nutr. 2019;121(2):221–31. https://doi.org/10.1017/S0007114518003070.

    Article  CAS  PubMed  Google Scholar 

  56. Roth RA, Wehrle KL. Nutrition & diet therapy. 12th ed. Boston: Cengage Learning; 2017. p. 253–4.

    Google Scholar 

  57. Jakše B, Jakše B, Pinter S, et al. Dietary intakes and cardiovascular health of healthy adults in short-, medium-, and long-term whole-food plant-based lifestyle program. Nutrients. 2019;12(1):55.

    Article  Google Scholar 

  58. Chomistek AK, Chiuve SE, Eliassen AH, Mukamal KJ, Willett WC, Rimm EB. Healthy lifestyle in the primordial prevention of cardiovascular disease among young women. J Am Coll Cardiol. 2015;65(1):43–51.

    Article  Google Scholar 

Download references

Acknowledgements

We sincerely thank all participants enrolled from High School “Istituto Istruzione Superiore”—“Valentini—Majorana”, Castrolibero (CS, Italy) and from sports teams of Cosenza, Paola and Crotone, located in Calabria Region, Italy. We are also thankful to all partners of the DIMENU project (Amphiios S.C.R.L., Istituto Istruzione Superiore—“Valentini—Majorana”, Castrolibero, ELLE 17 S.R.L.) and the Genotype-Tissue Expression (GTEx) Project that was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The data used for the analyses described in this manuscript were obtained from the GTEx Portal release V8 (dbGaP accession phs000424.v8.p2) on 04/30/21. Moreover, B.P. special thanks to Dr. Davide Guerra for his suggestions on the software used for analyzes conducted.

Funding

This research was supported by the EU Regional Operational Programme Calabria, Italy (POR Calabria FESR-FSE 2014–2020) DIMENU (prot. #52243/2017), and by the Department of Pharmacy, Health and Nutritional Sciences of University of Calabria (Italy) (Department of Excellence, Italian Law232/2016).

Author information

Author notes

  1. Daniela Bonofiglio and Francesca Luisa Conforti: Co-last authors

Authors and Affiliations

  1. Medical Genetics Laboratory, Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, Rende, CS, Italy

    Benedetta Perrone, Paola Ruffo & Francesca Luisa Conforti

  2. Olive Growing and Olive Oil Industry Research Centre, Agricultural Research Council, 87036, Rende, CS, Italy

    Samanta Zelasco

  3. Department of Pharmacy, Health and Nutritional Sciences, Via P Bucci, 87036, Rende, CS, Italy

    Cinzia Giordano, Catia Morelli, Ines Barone, Stefania Catalano, Diego Sisci & Daniela Bonofiglio

  4. Centro Sanitario, University of Calabria, Via P Bucci, 87036, Rende, CS, Italy

    Cinzia Giordano, Stefania Catalano, Sebastiano Andò, Diego Sisci, Daniela Bonofiglio & Francesca Luisa Conforti

  5. Institute of Clinical Physiology of Reggio Calabria, IFC-CNR, Reggio Calabria, Italy

    Giovanni Tripepi

  6. Medical Genetics Unit, Great Metropolitan Hospital BMM, Reggio Calabria, Italy

    Corrado Mammì

Authors
  1. Benedetta Perrone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Ruffo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samanta Zelasco
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cinzia Giordano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Catia Morelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ines Barone
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stefania Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sebastiano Andò
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Diego Sisci
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Giovanni Tripepi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Corrado Mammì
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Daniela Bonofiglio
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Francesca Luisa Conforti
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization, DB, FLC, BP, SA and DS; methodology, BP, PR, DS, CM and SZ; validation, BP and PR; formal analysis, BP, IB, GT, SC; investigation, BP; resources, DB, CG and FLC; data curation, BP and FLC; writing—original draft preparation, BP and FLC; writing—review and editing, BP, FLC, DB, CM and DS; visualization, BP and PR; supervision, CM, DB, FLC and DS; funding acquisition, DB and FLC. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Francesca Luisa Conforti.

Ethics declarations

Ethics approval and consent to participate

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the University of Calabria.

Consent for publication

Informed consent was obtained from all subjects involved in the study for research purposes.

Competing interests

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Table S1. Diet, lifestyle, and physical performance/sports - related genes examined in this study.

Additional file 2

Table S2. Annotated variants detected by targeted NGS analysis in our cohort.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perrone, B., Ruffo, P., Zelasco, S. et al. LPL, FNDC5 and PPARγ gene polymorphisms related to body composition parameters and lipid metabolic profile in adolescents from Southern Italy. J Transl Med 20, 107 (2022). https://doi.org/10.1186/s12967-022-03314-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12967-022-03314-w

Keywords

Journal of Translational Medicine

ISSN: 1479-5876

Contact us